Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

Japan

Kobe City Medical Center General Hospital, Kobe, Hyōgo

University of Tsukuba Hospital, Tsukuba, Ibaraki

Kyoto University Hospital, Kyoto, Kyoto

Osaka Metropolitan University Hospital, Osaka, Osaka